“…Thus, many clinicians tasked with training the next generation are unfamiliar with novel techniques, with rTMS being an example, and unable to facilitate the necessary learning and exposure. For these reasons, we and many others suggest that the time has come to formally define a subspecialty that concerns the application of waveform-based energy interventions (e.g., electromagnetic, ultrasonic) and intensive pharmacologic therapies (e.g., ketamine) for therapeutic purposes in neuropsychiatric conditions [7][8][9][10][11][12][13][14][15][16] . How this might look, and even if it is the best path forward, was the topic of a planned debate at the Clinical TMS Society (CTMSS) Annual Meeting that took place on Saturday, May 6, 2023, in Colorado Springs, CO.…”